Choongwae; new anti-colon cancer drug under development.

Choongwae and Japanese Chugai, an affiliate company of Roche, agreed on July 20 jointly to develope an innovative anti-cancer drug that had been studied since 2001 by Choongwae, initially for the treatment of colon cancer. Choongwae already developed the most optimized new candidate compound out of the leading substances group and finally agreed a technical license with Chugai.

Choongwae suc...